Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion type Assertion NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_head.
- NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion description "[Clinical investigations have suggested that repression of the TGF-? type II receptor (T?RII) may be an important step in progression of lung adenocarcinoma from an indolent in situ state to a frank invasive carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_provenance.
- NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion evidence source_evidence_literature NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_provenance.
- NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion SIO_000772 21911454 NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_provenance.
- NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion wasDerivedFrom befree-2016 NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_provenance.
- NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_assertion wasGeneratedBy ECO_0000203 NP923250.RA6tMqKdldVNe6NAYA0SR6AaBnIBk-5-gweR5OIjbngXI130_provenance.